MO1-3 Real-world data of first-line treatment with pembrolizumab for NSCLC with high PD-L1 expression (HOT/NJLCG2001 secondary report)
- Resource Type
- Abstract
- Authors
- Tateishi, Kazunari; Mizugaki, Hidenori; Ikezawa, Yasuyuki; Morita, Ryo; Yokoo, Keiki; Sumi, Toshiyuki; Kikuchi, Hajime; Kitamura, Yasuo; Nakamura, Atsushi; Kobayashi, Maki; Aso, Mari; Kimura, Nozomu; Yoshiike, Fumiaki; Furuta, Megumi; Tanaka, Hisashi; Sekikawa, Motoki; Hashiya, Tsutomu; Fujita, Yuka; Oizumi, Satoshi
- Source
- In Annals of Oncology November 2023 34 Supplement 3:S1394-S1394
- Subject
- Language
- ISSN
- 0923-7534